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Abstract
Background: Heart failure (HF) prevalence is increasing in the United States.
Mechanical Circulatory Support (MCS) therapy is an option for Advanced HF
(AdHF) patients. Perioperatively, multiorgan dysfunction (MOD) is linked to the
effects of device implantation, augmented by preexisting HF. Early recognition of
MOD allows for better diagnosis, treatment, and risk prediction. Gene expression
profiling (GEP) was used to evaluate clinical phenotypes of peripheral blood
mononuclear cells (PBMC) transcriptomes obtained from patients’ blood samples.
Whole blood (WB) samples are clinically more feasible, but their performance in
comparison to PBMC samples has not been determined.
Methods: We collected blood samples from 31 HF patients (57¡15 years old)
undergoing cardiothoracic surgery and 7 healthy age-matched controls, between
2010 and 2011, at a single institution. WB and PBMC samples were collected at a
single timepoint postoperatively (median day 8 postoperatively) (25–75% IQR 7–14
days) and subjected to Illumina single color Human BeadChip HT12 v4 whole
genome expression array analysis. The Sequential Organ Failure Assessment
(SOFA) score was used to characterize the severity of MOD into low (# 4 points),
intermediate (5–11), and high ($ 12) risk categories correlating with GEP.
Results: Results indicate that the direction of change in GEP of individuals with
MOD as compared to controls is similar when determined from PBMC versus WB.
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The main enriched terms by Gene Ontology (GO) analysis included those involved
in the inflammatory response, apoptosis, and other stress response related
pathways. The data revealed 35 significant GO categories and 26 pathways
overlapping between PBMC and WB. Additionally, class prediction using machine
learning tools demonstrated that the subset of significant genes shared by PBMC
and WB are sufficient to train as a predictor separating the SOFA groups.
Conclusion: GEP analysis of WB has the potential to become a clinical tool for
immune-monitoring in patients with MOD.
Introduction
Heart failure (HF) affects more than 5 million people in the United States.
Mechanical Circulatory Support (MCS) therapy is a current temporary strategy
for patients with end-stage HF who are not candidates for heart transplantation.
Because of the limited availability of donor organs and the approval of MCS for
long term (destination) therapy, the use of MCS therapy has grown rapidly over
the last 10 years. MCS therapy is considered in patients who are no longer
responsive to medical treatment, patients that are not candidates for heart
transplantation (as destination or lifetime therapy), patients who are awaiting a
heart transplant and/or are becoming too sick due to progressive heart failure, and
also in patients with HF in whom myocardial function is expected to return to
normal in a short period of time (as a bridge to recovery) [1]. Outcomes after
MCS therapy have significantly improved, yet 10–20% of patients die during the
first year post MCS-implantation, usually from sepsis and Multi Organ
Dysfunction Syndrome (MOD) [2]. MOD is linked to an altered immune
response induced by the device and the surgical procedure, and is influenced by
the preexisting HF [3] [4] [5]. Multiple abnormal immune functions describe the
critically ill patient: aberrant systemic inflammatory response syndrome (SIRS),
altered production of antibodies, abnormal lymphocyte response regulation,
release of chemical mediators including cytokines, nitric oxide, endothelin, and
prostaglandins [6] [7] [8].
Risk prediction tools are commonly used in clinical practice to estimate
outcomes. Among them is the Sequential Organ Failure Assessment (SOFA) score,
which is useful to predict MOD following MCS therapy. Mortality and length of
stay in the ICU and the hospital can be estimated by cross-sectional values of
initial score or highest score as well as temporal changes in the SOFA score.
Survival is limited for MCS patients with MOD who have high SOFA scores [9].
Early recognition of MOD has important implications in diagnosis, treatment and
risk stratification of patients with AdHF undergoing high risk cardiovascular
interventions such as MCS, high risk cardiac revascularization, or valve
replacement.
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However, the SOFA score as well as all other currently available risk scoring
tools for MOD ICU patients do not incorporate parameters of immune function,
i.e. indicators of the inflammatory response, even though MOD is linked to an
exaggerated leukocyte-mediated SIRS. Therefore, we propose a comprehensive
evaluation of the immune response associated with MCS implantation and states
of multiorgan injury. After completion of the human genome project, global
(whole transcriptome) methods of gene expression profiling (GEP) of various
tissues and blood cell types have become available for genome-wide evaluation of
clinical phenotypes that can now be used to improve clinical evaluation in
multiple disease settings. [10] [11] [12] [13] [14] [15]. We have previously
developed a PBMC GEP test to rule out heart transplant rejection [27],
implemented the test clinically, showed its clinical utility [43] and showed its
potential to predict clinical events after heart transplantation [42], and
demonstrated the feasibility of PBMC whole transcriptome GEP in AdHF-patients
undergoing MCS-implantation [44]. In this setting, evaluation of the information
contained in the PBMC transcriptome may provide a promising solution to this
important missing point in the assessment of the critically ill patient.
In the ICU-setting, there are specific challenges to overcome in the
development of novel genomic diagnostics. First, several methodological
challenges apply to PBMC GEP, which may interfere with reproducibility through
the addition of systematic bias when used in the setting of multicenter studies [6]
[23] [24] [25] [26] [27] [28] [29]. Second, when approaching the evaluation of
critically ill patients, the amount of blood that is obtained may add a complication
to the process of recovery. PBMC processing for leukocyte isolation requires 8 ml
of blood while WB methods require only 2.5 ml. These patients require multiple
blood draws and efforts to minimize loss that is considered in the best interest of
the patients. Third, these patients are exposed to blood transfusion, medications,
and different degrees of oxygen saturation and fluid loading which could
potentially cause error in the results. (Fig. 1).
It is known that there is a significant overlap between WB and PBMC gene
expression [16]. A study by Whitney et al (2003) found that the proportions of the
variety of cell types in peripheral blood can affect the GEP of a patient and that
these proportions can rapidly change after an inflammatory response [18]. Debey
et al (2004) compared the effect of different isolation techniques in gene
expression experiments and found that PBMC analysis yields a more sensitive
diagnosis as compared to WB [19]. However, Freezor et al (2004) and Palmer et al
(2006) discovered that the process was laborious and could affect the GEP [20]
[21]. Most recently, Min et al (2012) evaluated the variability of GEP in human
blood and lymphoblastoid cell lines. They showed a significant overlap in the gene
expression profiles between WB and PBMC [22].
An important aspect concerning the applicability of new techniques that can be
rapidly translated into clinical practice involves its feasibility, reproducibility, cost
effectiveness, and ease of implementation, and application. For practical and
methodological reasons, such studies are usually performed using purified PBMC
samples. However, use of PBMC is labor-intensive and requires several
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methodological steps that must be strictly followed [16] [21] [23]. As an
alternative, easy-to-use WB gene expression methods have been developed for
clinical applications [30]. While comparisons have already been done for gene
expression of PBMC and WB supporting the use of both methodologies, it is not
known whether the same principles can be applied to critically ill patients
undergoing complex surgical procedures [33]. These patients are usually exposed
to multiple factors such as repeat blood transfusions, hemodilution, stressors and
drugs which could interfere with the applicability of WB gene expression
methodologies to this specific population.
Therefore, we hypothesize that mRNA profile of WB from patients with MCS
can be used as a surrogate for mRNA profile of PBMC of patients with MCS to
identify transcriptome fingerprints for biomarker discovery in various degrees of
MOD [30], [31], [37].
Methods
Ethics statement
This study was approved by the Columbia University Office of Human Research
Protection Program IRB # 2206 and all patients signed an informed consent.
Patients
We collected blood samples from 31 consecutive HF patients (57¡15 years old)
undergoing cardiothoracic surgery (n529 MCS, n51 coronary artery bypass
surgery (CABG) + aortic valve replacement (AVR), n51 transcatheter aortic valve
replacement (TAVR) and 7 healthy age-matched controls). Samples were obtained
between March 2010 and May 2011 at a single institution. PBMC was available for
30 patients and 7 controls, and WB was available for 31 patients and 3 controls.
Main characteristics of the study samples are summarized in Table 1.
Samples were collected at a single time-point postoperatively at a median of 8
days after device implantation (25–75% IQR 7 – 14 days). The variability of the
day 8 sampling time point was dictated by the clinical circumstances. To assess for
MOD, we utilized the SOFA score. The SOFA score is a simple, validated, and
widely accepted tool that can be easily obtained at a patient’s bedside and is used
to assess patient’s disease severity and predict survival in the critical care unit [40].
Fig. 1. Variability of methodologies in the processing of gene expression in WB and PBMC.
doi:10.1371/journal.pone.0115097.g001
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This score has been applied to different study populations including patients with
MCS [41]. SOFA is an integer score that assigns a numerical variable to each of 6
major organ systems to quantify the severity of organ failure. Values range
between 0 and 4. Each system’s value is summed into a single SOFA score.
Therefore the sum score ranges between 0 to 24 and correlates with the severity of
MOD and clinical outcomes. Following our previous studies [42], [43], [44], [45],
we divided the population into SOFA score risk subgroups which were defined as
low (# 4 points), intermediate (5–11), and high ($ 12). SOFA score was
computed for each patient at the time that gene expression samples were
obtained.
Sample collection and RNA isolation
Blood was drawn and collected into PaxGene tubes (Becton Dickinson, Franklin
Lakes, NJ) for the WB mRNA gene expression analysis or into a CPT tube (Becton
Dickinson, Franklin Lakes, NJ) for PBMC cell isolation. For the WB samples,
2.5ml of blood were collected using PaxGene tubes. Samples were incubated at
room temperature for 2 hours for RNA stabilization and then stored at 280 C˚.
RNA was extracted from WB using the PAXgene Blood RNA Kit (Qiagen,
Valencia, CA) according to the manufacturer’s protocol which includes a globin
reduction step. Briefly, samples were removed from280 C˚ and incubated at room
temperature for 2 hours. Following lysis, the tubes were centrifuged for 10 min at
5,0006g, the supernatant was discarded and 500mL of RNase-free water was
added to the pellet. Subsequently, the tubes were vortexed thoroughly to re-
suspend the pellet, centrifuged for 10 min at 50006g and the entire supernatant
was discarded. The pellet was re-suspended in 360mL of buffer BR1 by vortexing
and further purification of RNA was done following the manufacturer’s protocol
with on-column DNase digestion.
For the PBMC samples, mononuclear cells were isolated from 8 ml of blood
collected by Vacutainer cell preparation tubes (CPT) with sodium citrate (Becton
Dickinson, Franklin Lakes, NJ), resuspended in RNeasy Lysis Buffer (RLT,
Qiagen, Valencia, CA) within 2 hours of phlebotomy. Total RNA was isolated
from each sample (RNeasy, Qiagen, Valencia, CA). Quality of the purified RNA
was verified on an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto,
Table 1. Characteristics of the patients.
Age Days SOFA Gender
median (Q1:Q3) n (%)
Control 52(44.5:55.25) 0(0:0) 5(62.5)
Low 64(53:70.5) 12.5(18.75:8) 4(4:2.5) 13(92.9)
Medium 60.5(47.5:66.75) 7(9.75:7) 7(8.75:5.25) 5(50)
High 60.5(56.5:65.25) 8.5(20.25:4.5) 16.5(19:13.75) 3(37.5)
Calculations are based on all subjects participating in the study. There were 31 WB samples and 30 PBMC samples from patients and 7 and 3 PBMC and
whole blood controls respectively.
doi:10.1371/journal.pone.0115097.t001
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CA); RNA concentrations were determined using a NanoDrop ND-1000
spectrophotometer (NanoDrop Technologies, Wilmington, DE).
Microarray data processing and analysis
After RNA extraction, quantification and quality assessment, total mRNA was
amplified and hybridized on the Illumina single color Human BeadChip HT12 v4
whole genome expression array. Each array targets more than 47,000 probes
derived from the National Center for Biotechnology Information Reference
Sequence (NCBI) RefSeq Release 38 (November 7, 2009) and other sources. All
samples were processed in a single core facility. After hybridization and
microarray chip processing, feature extraction was carried out in the Illumina
Beadarray platform (Illumina, San Diego, CA). Data was then subjected to
quantile normalization using GenomeStudio (Illumina, San Diego, CA) and
normalized expression files for PBMC and WB were used hereafter for
comparison.
Filtering was done against background and only those probes having more than
20% variation in the gene expression were retained. Probes mapping to the same
gene transcript were not averaged. Data was then transferred to GeneSpring GX 12
(Agilent, Palo Alto, CA). Sample data was normalized using the Quantile
normalization method and quality control carried out as implemented in
GeneSpring [46]. Given that the starting dataset showed a significant amount of
noise in the signal for the WB samples, data was further assessed for the coefficient
of variation for each entity within risk groups so only those with a coefficient
lower than 0.75 in at least one group were kept for subsequent analysis. This
criterion was employed to reduce the intra-group variability, thereby selecting the
most reliable entities for potential biomarker candidates.
Quantitative Real-time Polymerase Chain Reaction (RT-qPCR) and
Validation
Microarray data were validated by Quantitative PCR on PBMC and WB obtained
from an independent set of samples. Total RNA from PBMC cells were purified
using RNeasy Mini Kit (Qiagen, Valencia, CA) and total RNA from WB cells were
purified using the MagNA pure Compact System (Roche, Pleasanton, CA). CDNA
was synthesized with iScript supermix for RT-qPCR (BioRad, Hercules, CA). RT-
qPCR analysis was carried out with iTaq SYBR green supermix (BioRad, Hercules,
CA) on the 7500 Fast Real-time PCR system (Applied Biosystems, Foster City,
CA). 18S rRNA levels were used as an internal control for real-time PCR.
Sequences of the primer pairs used were as follows: 18S rRNA, 59-GTAACCC-
GTTGAACCCATT-39 and 59-CCATCCAATCGGTAGTAGCG-39; IL11RA, 59-
ACTTCCTGCTCAAGTTCCGT-39 and 59-GGCACTGACTCGTACAGCAT-39;
IL2RB, 59-TTCTAGCGTCAGTGCTGGAG-39 and 59-CCTCAGAGATCCCAAA-
GGAA-39; TRAF3IP3, 59- GAGGCTCTGAAGGAGGACTG-39 and 59- TATCT-
GCTCCCTGCAGTTTG-39; LAT2, 59- CTACCCACCTGTCACCTCCT-39 and 59-
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CTGTTGGCACCATCAGAATC-39; CCL5, 59- AAGGAAGTCAGCATGCCTCT-
39 and 59- TTTGCCAGTAAGCTCCTGTG-39; GNLY, 59-TTCTAGCGTCAG-
TGCTGGAG-39 and 59- ATGCCTTTCACACCCTGTTT-39; MAP4K1, 59- AAG-
ATCCAGGACACCAAAGG-39 and 59- CTGGTACCACTGAAGCAGGA-39;
ABLIM1, 59- GTGCAGTTCCCATGAGTCAC-39 and 59- GGACAATGGTTT-
CCTCTGCT-39; CD96, 59- AACACCATGGCTGTCACACT-39 and 59- AGGC-
TCGATGGTTCTCAACT-39; GRB10, 59- GCAGCCAGTCAGTCTTTCAA-39 and
59- GCAGCCAGTCAGTCTTTCAA-39.
Statistical analysis of gene expression
Normalized gene expression samples of normal controls were used as the reference
against which samples from patients with low, medium, and high SOFA scores
were compared. Statistical comparison was done by the Kruskal-Wallis analysis of
variance method and corrected for multiple hypotheses testing using the
Benjamini-Hochberg method. Genes that satisfied the significance criteria of less
than 5% false discovery rate (FDR) were further analyzed for the enrichment of
gene ontology (GO) and subjected to pathway analysis. For the GO analysis, we
used High-Throughput GoMiner (HTGM) [47] (http://discover.nci.nih.gov/) to
analyze the enrichment of GO categories by up- and down-regulated genes for
both WB and PBMC [48]. HTGM analyzes data from all microarrays in a study,
provides diagnostics for data interpretation, and allows visualization in the form
of clustered heat maps [49]. Normally, the input to HTGM consists of a total-
genes file (representing the entire Microarray or a randomly generated whole
genome seed) and a changed-genes file (representing the genes with altered
expression) relevant to the study purpose. The output generated by HTGM
includes a summary of the results, a matrix whose rows are categories and whose
columns are names of changed gene for hierarchical clustering of experiments and
categories, and a statistical summary for each category including one-sided Fisher
exact p-value and an FDR. Hierarchical clustering of enriched categories and
changed genes allows determining which categories achieved statistical signifi-
cance by virtue of containing essentially the same set of changed genes. For
pathway analysis, we used the algorithm incorporated in Genespring, testing for
differentially expressed genomic pathways based on the available repositories
including Biopax, Wiki, and Reactome. A pathway list was obtained based on
Entrez Gene ID and UniGene ID.
To assess the performance of PBMC and WB for biomarker development, we
examined the accuracy of predicting the high-risk SOFA group subjects across
data sets using the Support Vector Machine (SVM) Class Prediction module in
GeneSpring GX 12 (Agilent, Palo Alto, CA), we trained linear kernel SVMs on the
PBMC and WB gene datasets defined by the significance criteria described above,
as well as the gene set defined by the intersection of these two sets and evaluated
the misclassification rates between SOFA groups when each of these trained SVMs
were applied to either dataset in its entirety.
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Results
PBMC versus WB Differential Gene Expression (HF versus
Controls)
A general workflow of the analysis depicting differential gene expression for both
groups is presented in Fig. 2.
The work presented here is the comparison between PBMC and WB whole
transcriptome GEP and their correlation to the SOFA score. The combined risk
groups of all 31 HF patients exhibited 2605 gene transcripts (2305 genes
differentially expressed) in the PBMC and 446 (400 genes differentially expressed)
in the WB dataset that had at least a 1.5 fold change in their expression level
compared to healthy age-matched controls. While substantially more gene
transcripts were differentially expressed in the PBMC compared to WB, there was
a significant overlap among them with 333 genes (83.2%) shared by WB and
PBMC. The direction of gene expression between WB and PBMC was consistent
for 229 genes (68.7%) in the low risk compared to the control group, 245 genes
(73.5%) in the medium risk group, and 251 genes (75.4%) in the high risk group.
A list of the highest differentially expressed genes overlapping in WB and PBMC is
provided in Table 2. A list of the overlapping genes and their Pearson correlations
with the SOFA score, in both WB and PBMC, is included in the S2 Table. A
complete list of genes both overlapping and non-overlapping for each dataset is
also provided in the S1 Table.
PBMC versus WB Biomarker Candidate Gene Discovery
Expression patterns of the highest differentially expressed genes have been
clustered as a heatmap for visualization purposes and provided in Fig. 3.
This shows that patterns of the highest differentially expressed genes have
similar profiles for PBMC and WB. For these genes, we used text mining
algorithms as implemented in GeneSpring to identify those with the highest
connectivity and most likely to have an important role in the inflammation
process. These genes included IL11RA, CCLS, GNLY, MAP4K1, LAT2, CD96,
GRB10, and IL2RB.
Validation of PBMC and WB differentially regulated genes by RT-
qPCR
To validate the microarray results in this study we used an alternative approach.
We performed RT-qPCR to assay the 10 highest ranked genes, ranked first by
statistical significance, secondly by correlation between WB and PBMC
microarray expression levels, and finally by biological relevance (Table 3).
To perform this validation, we analyzed RT-qPCR of 8 samples taken from
across control, low/medium, and high SOFA score groups. Fold changes were
calculated against control, averaged in each group by their logarithms, and
transformed back. We compared the microarray and RT-qPCR results of
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expression of 10 genes between the SOFA score sub-groupings within the PBMC
and WB groupings (Fig. 4).
PBMC versus WB Gene Ontology analysis
GO analysis identified 314 terms enriched by 1327 genes. 35 of these terms
overlapped between WB and PBMC. GO categories included regulation of the
immune response and related pathways including the innate and the adaptive
immune responses. Interestingly, there was a pronounced enrichment of innate
response GO terms by up-regulated genes and of the adaptive immune response
by down-regulated genes as previously described in the setting of critical illness
[16]. Other enriched GO terms were related to programmed cell death and the
coagulation cascade, both well known to be involved in the biology of critical
illness [17]. The identification of these processes in the context of the known
biology supports the validity of our findings as opposed to random enrichment of
GO categories. The overall enrichment found in the PBMC dataset compared to
WB showed that the majority of genes, while different, were likely involved in
similar biological processes. Thus, GO analysis suggests that for both PBMC and
WB, expressed genes are involved in inflammation, apoptosis, and stress response
related pathways among others. There is a significant difference in the number of
GO categories but not in the processes represented by these categories. The lack of
a significant enrichment of GO categories or members of a specific gene pathway
Fig. 2. Flowchart of data analysis.
doi:10.1371/journal.pone.0115097.g002
Comparison Inflammatory Response of WB and PBMC GEP in AdHF Patients
PLOS ONE | DOI:10.1371/journal.pone.0115097 December 17, 2014 9 / 22
Table 2. Most relevant representatives of the overlapping up- and down-regulated genes expressed in PBMC and WB between patients after intervention.
Gene symbol
Corrected p-
value Low SOFA score Medium SOFA score High SOFA score
Fold Change
(PBMC) Regulation Fold Change Regulation Fold Change Regulation
DARC 0.043 21.320 down 22.191 down 23.601 down
ENO2 0.007 21.431 down 21.735 down 22.222 up
WDR45 0.047 1.409 up 1.801 up 1.833 up
D40LG 0.005 22.066 down 22.702 down 23.653 down
CD8B 0.006 21.563 down 21.798 down 22.359 down
LCK 0.005 21.848 down 22.431 down 23.232 down
FCGBP 0.005 22.514 down 22.900 down 24.858 down
IL2RB 0.005 22.473 down 22.879 down 28.016 down
CCL5 0.005 21.559 down 21.975 down 26.794 down
CD8A 0.005 22.182 down 23.299 down 28.575 down
ICAM2 0.018 21.637 down 21.606 down 22.065 down
CD79B 0.005 21.642 down 21.536 down 23.059 down
HLA-DQA1 0.009 21.778 down 22.170 down 26.841 down
CD3G 0.005 21.719 down 22.177 down 23.780 down
CD3D 0.005 22.027 down 23.295 down 27.713 down
IL32 0.005 21.569 down 22.172 down 23.799 down
VSIG4 0.005 1.257 up 1.962 up 10.599 up
S1PR5 0.005 22.610 down 22.857 down 27.143 down
CD3D 0.005 22.026 down 23.154 down 27.734 down
ITM2A 0.005 21.913 down 22.792 down 25.529 down
IL1R2 0.011 1.135 up 1.976 up 15.480 up
KLRD1 0.005 21.941 down 22.374 down 26.028 down
CD79A 0.005 21.842 down 21.809 down 23.061 down
CD3E 0.005 21.837 down 22.734 down 24.568 down
PTGDS 0.009 21.752 down 22.099 down 23.329 down
TLR9 0.045 21.168 down 21.240 down 21.277 down
GZMB 0.006 22.316 down 22.226 down 27.583 down
CX3CR1 0.007 21.200 down 21.012 down 23.954 down
AHSP 0.014 23.029 up 28.623 up 64.306 up
C19orf2 0.016 21.469 down 21.476 down 21.823 down
TRADD 0.006 21.453 down 21.795 down 22.209 down
CD96 0.005 22.256 down 22.748 down 24.935 down
IL11RA 0.006 21.783 down 22.298 down 23.334 down
CD8A 0.006 22.283 down 23.234 down 28.740 down
BCL2 0.005 21.341 down 21.854 down 23.008 down
FCER1A 0.005 22.269 down 23.763 down 210.177 down
GZMA 0.006 22.062 down 22.194 down 27.656 down
IL7R 0.005 22.319 down 23.891 down 27.479 down
FAM102A 0.005 22.212 down 22.908 down 24.824 down
SPOCK2 0.005 21.935 down 23.351 down 25.789 down
SBK1 0.005 22.070 down 22.698 down 25.390 down
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in the WB dataset could be explained by different power assumptions when
starting from a smaller number of genes. However, differences in the direction of
gene expression could be explained by multiple mechanisms that reside in the
interface between WB composition and PBMC and need to be further
investigated. Genes in the overlap dataset include members of pathways such as
Apoptosis (BCL2, MAGED1, and TNFRSF10B), Nephrin interactions (FYN),
CD28 and CD28 co-stimulation (CD28r), Cell-extracellular matrix interactions
(BCL2, LAT2, KLFR1, KLRD1, TRAT1, PTCRA, KLRB1, and ICAM2), Antiviral
mechanism mediated by Interferon gamma signaling (IL1R2 and IRAK3), and
Lipoprotein metabolism including LDL-mediated lipid transport, and
Chylomicron-mediated lipid transport (LPL, VLDL, and TGIHDL). The most
relevant GO categories enriched in PBMC and WB are described in Table 4.
Table 2. Cont.
Gene symbol
Corrected p-
value Low SOFA score Medium SOFA score High SOFA score
Fold Change
(PBMC) Regulation Fold Change Regulation Fold Change Regulation
CXCR5 0.010 21.858 down 22.112 down 22.693 down
IL7R 0.005 22.418 down 23.905 down 28.217 down
CD247 0.005 22.436 down 23.467 down 29.013 down
CD2 0.005 22.245 down 23.349 down 27.121 down
GPR56 0.006 22.228 down 22.612 down 29.470 down
GNLY 0.005 22.189 down 22.584 down 29.530 down
MYC 0.022 21.383 down 21.770 down 22.474 down
GNLY 0.005 22.302 down 22.738 down 29.103 down
HP 0.011 3.279 up 4.755 up 6.795 up
STAT4 0.005 22.161 down 3.066 down 5.837 down
doi:10.1371/journal.pone.0115097.t002
Fig. 3. Clustered heatmap of the overlapping 333 genes in WB and PBMC shows highly correlated gene expression patterns.
doi:10.1371/journal.pone.0115097.g003
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Of particular interest in the heatmap (Fig. 3) are the areas where multiple GO
categories overlap or ‘‘cross-talk’’, suggesting that mechanisms involved for a
specific set of genes are common to different biological processes. Those GO terms
were related to molecular mechanisms associated with inflammation leading to T-
cell activation, activation of cytokine signaling cascades, and regulation of
programmed cell death. Other important biological processes identified in the
non-overlapping genes included ‘‘cross-talking’’ GO categories involving regula-
tion of peptidase, caspase, and endopeptidase activity. A complete list of
overlapping and non-overlapping GO categories is provided in S3 Table.
PBMC versus WB Pathway analysis
The total number of differentially expressed pathways associated with up- or
down-regulated genes was 26 in the WB dataset and 265 in the PBMC dataset. A
total of 137 genes present in the WB pathway enrichment analysis were also
included in the list of genes from PBMC pathways (466). The enrichment analysis
revealed that 26 pathways were associated with up-regulated genes based on a
Table 3. Differentially expressed, highest connected genes sorted by connectivity (n).
Gene (Number of Connectivity) Function Disease
IL11RA- Interleukin 11 Receptor, Alpha Stromal cell derived cytokine, uses gp130 transducing subunit in their high affinity
receptors, members of the hematopoietic cytokine family.
Megakaryocytic leu-
kemia
IL2RB- Interleukin 2 Receptor, Beta T-cell mediated immune response. Intermediate and high affinity forms of IL2RB
involved in receptor-mediated endocytosis and transduction of mitogenic signals
from IL-2.
Occipital neuralgia,
and granulomatous
orchitis
TRAF3IP3- TRAF3 Interacting Jun N Terminal
Kinase (JNK) Activating Modulator
Mediates cell growth through modulating c-Jun N-terminal kinase signal
transduction pathway.
Rectum cancer,
cerebral cavernous
malformations 3.
LAT2- Linker for Activation of T-Cells Encoded protein is phosphorylated by ZAP-70/Syk protein tyrosine kinases
following activation of the T-Cell antigen receptor (TCR) signal transduction
pathway. Protein then recruits multiplied adaptor proteins and downstream
signaling molecules into multi-molecular signals.
Mitral valve steno-
sis, and alexia.
CCL5- Chemokine (C-C Motif) Ligand 5 Chemokine superfamily; member of the CC subfamily. Chemoattractant for blood
monocytes, memory T helper cells and eosinophils. Causes histamine release
from basophils and activates eosinophils. Cytokine is an HIV-suppressive factor
produced by CD8+ cells.
Ulcer of lower limbs,
meningoencephali-
tis.
GNLY- Granulysin Saposin-like protein (SAPLIP). Present in cytotoxic granules of cytotoxic T-
lymphocytes and NK cells. Has antimicrobial activity against M. Tuberculosis and
other organisms.
Folliculitis, and
spondylocostal dys-
ostosis.
MAP4K1- Mitogen-Activated Protein Kinase
Kinase Kinase
Protein coding. Gene associated with pancreatic cancer and pancreatitis. Pancreatic cancer,
and pancreatitis
ABLIM1- Actin binding LIM protein 1 Encodes a cytoskeletal LIM protein that binds to actin filaments via a domain that
is homologous to erythrocyte dematin. LIM domains also function as protein
binding interfaces, mediating specific protein-protein interactions.
Corneal neovascu-
larization and alco-
hol dependence
CD96- CD96 Molecule Type-1 membrane protein, immunoglobulin superfamily. Adhesive interactions of
T-Cells and NK cells in late stage of immune response.
Cat eye syndrome
and c-like syn-
drome
GRB10- Growth factor receptor bound protein 10 Small family of adapter proteins-interact with several receptor tyrosine kinases
and signaling molecules. Encodes a growth factor receptor-binding protein that
interacts with insulin receptors and insulin-like growth factor receptors.
Silver-russell syn-
drome, albright’s
hereditary osteody-
strophy.
doi:10.1371/journal.pone.0115097.t003
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Fig. 4. RT-qPCR validation of three differentially expressed genes within PBMC and WB subgroups, within SOFA groups. Darker colors correspond
to higher magnitude of fold change. Fold changes showed similar patterns between all 10 genes, 9 of which are down-regulated, and 1 of which is up-
regulated. 7 of 10 genes showed similar patterns between PBMC and WB and also within SOFA score groups according to our microarray and PCR results.
2 of 10 genes (IL11RA and GRB10) show an opposite result in HIGH PCR (PBMC) and low/med array (WB) correspondingly. Only 1 gene, MAP4K1, shows
an opposite result between SOFA score groups.
doi:10.1371/journal.pone.0115097.g004
Table 4. Most relevant representative of GO categories overlapping between PBMC and WB after intervention.
GO accession GO Term FDR N selection % selection N Total % Total
GO:0001817 regulation of cytokine production 0.061 37 1.4020462 125 0.747
GO:0002376 immune system process 0.000 243 9.208034 823 4.921
GO:0002682 regulation of immune system process 0.000 85 3.220917 257 1.537
GO:0006915 apoptosis 0.011 98 3.713528 425 2.541
GO:0010941 regulation of cell death 0.000 135 5.115574 545 3.259
GO:0042101 T cell receptor complex 0.000 11 0.41682455 12 0.072
GO:0045321 leukocyte activation 0.014 51 1.9325502 178 1.064
GO:0046649 lymphocyte activation 0.006 46 1.7430845 149 0.891
doi:10.1371/journal.pone.0115097.t004
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corrected 2-tailed p-value ,0.05 (5% FDR). Pathways differentially regulated in
WB that were common to PBMC included the adaptive immune system. Out of
40 genes listed under the adaptive immune system pathway, 10 genes (25%) in the
WB dataset were differentially expressed and 15 genes (37.5%) in the PBMC
dataset were differentially expressed (p-values,0.001). Genes in this pathway
including ITK, LAT, LCK, and TRAT1 were found to be up-regulated in both
PBMC and WB. Eleven genes were up-regulated in PBMC but down-regulated in
WB. The T-Cell receptor signaling pathway showed an enrichment of 30% (7/23
genes, (p5 3.8610209). Other important pathways included apoptosis, home-
ostasis, and those associated with HIV infections, CD28 and GPCR signaling.
Significantly enriched pathways and corresponding gene expression are listed in
Table 5.
For the pathway analysis, we found that of the 34 significant genes that
overlapped between PBMC and WB pathway groups, 26 had concordantly
regulated patterns in both groups. The other 8 genes showed an opposite
expression in PBMC and WB datasets. Results observed in the WB samples were
similar in several aspects to those in the PBMC datasets, supporting the role of
these genes as potential biomarkers for early diagnosis and monitoring of MOD.
Variations in the direction of gene expression suggest that perturbations in
multiple signaling and cellular mechanisms occur in a comparable way in PBMC
as in WB.
Performance of classification using PBMC and WB
We employed a support vector machine (SVM) to examine the accuracy of
predicting the high-risk SOFA group subjects across data sets. Misclassification
rates between the SOFA groups, when each of these trained SVMs was applied to
either dataset, are shown as confusion matrices in Table 6.
We found that the SVM trained on the WB genes were accurate in predicting
the medium and high risk SOFA subjects in the PBMC dataset (a), and the
overlapping PBMC genes were accurate in predicting the medium and high risk
SOFA subjects in the WB dataset (d). Also, training on only the overlapping
PBMC genes was sufficient to accurately predict all patients in the PBMC group
(c). However, training on all PBMC genes was not useful in predicting in the WB
group because the SVM relies heavily on information about genes that were not
significant in the WB dataset (b).
Discussion
In this paper, we show that WB can be used as a surrogate of PBMC expression in
a set of critically ill patients who underwent AdHF cardiac surgery. We validate
this result with independent set of samples using RT-qPCR. Our results indicate
that the direction of change in gene expression profiles of individuals with MOD
as compared to controls is similar when determined from PBMC versus WB. In
Comparison Inflammatory Response of WB and PBMC GEP in AdHF Patients
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Table 5. Pathway analysis by overlapping up- and down-regulated genes expressed in PBMC and WB after intervention.
Genes which overlap in PBMC and WB
Pathways have same direction within pathway have opposite direction within pathway
PBMC and WB PBMC WB
down up down up down up
Immune System BTLA TRAT1 TRAT1
LAT
PLCG1
PRKCQ
ZAP70
Adaptive Immune System ITK BTLA FYN FYN BTLA
LAT CARD11 CARD11
LCK
TRAT1
Immunoregulatory interactions
between a Lymphoid and a
non-Lymphoid cell
CD160 CD40LG KLD1 KLD1 CD40LG
CD96
Costimulation by the CD28
family
ITK LAT
Chemokine receptors bind
chemokines
CCL5
CCL7
CXCR6
HIV Infection LCK CD247 NMT2 NMT2 CD247
Apoptosis BCL2 GZMB TRADD TRADD GZMB
MAGED1 PRKCQ PRKCQ
TNFRSF10B
Class A/1 (Rhodopsin-like
receptors)
CCR7 GPR18 CCL5 CCL5 GPR18
CXCR6 CXR5 CXR5
GPR44
Hemostasis CD2 FYN FYN
JAM3 LAT LAT
KIFAP3
LCK
MAFG
PLCG1
Nef and signal transduction CD247
FYN
Network Regulators CD8A CD3D CD3G CD3G CD3D
Signal Transduction PLCG1
SH3KBP1
GPCR ligand binding CXCR5 CCL5 CCR7 CCR7 CCL5
GPR18 CXCR6 CXCR6
GPR44
Signaling by GPCR CXCR5 CCL5 CCR7 CCR7
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each of the low, medium and high risk SOFA score patients; there was consistency
in the direction of gene expression changes. The main enriched terms by GO
analysis included those involved in the inflammatory response, apoptosis, and
other stress response related pathways. The data revealed that there were 35
significant GO categories and 26 pathways overlapping between PBMC and WB.
Additionally, class prediction using machine learning tools demonstrate that the
subset of significant genes shared by both PBMC and WB are sufficient to train a
predictor separating the SOFA groups.
Overall, multiple explanations can be postulated to support our findings. First,
the differences between PBMC and WB could be secondary to lower signal-to-
noise ratios in WB, leading to a higher number of false positive rates when tested
with multiple comparisons. Thus, a way to reduce the ratio of true positives to
true negatives required an additional step in filtering those transcripts with high
intraphenotypic variability that would otherwise be removed by multiple
hypothesis testing. As a positive consequence, only those transcripts that are more
stable across phenotypes are retained for the analysis, providing a more
Table 5. Cont.
Genes which overlap in PBMC and WB
Pathways have same direction within pathway have opposite direction within pathway
PBMC and WB PBMC WB
down up down up down up
CXCR6
GPR18
GPR44
Signaling by Interleukins IL1R2 IL2RB IL7R IL7R IL2RB
IRAK3
Small Molecules LCK PRKCQ PRKCQ
PLCG1 PLCG1
SIGIRR SIGIRR
TCR signaling LAT CARD11 CARD11
PLCQ1 ITK ITK
PRKCQ
TRAT1
ZAP70
The role of Nef in HIV-1
replication and disease
pathogenesis
CD247 LCK LCK
FYN
Toll Receptor Cascades SIGIRR IRAK3 IRAK3
TLR5
Peptide ligand-binding
receptors
CXR5 CCL5 CCL5
CCR7 CCR7
CXR6 CXR6
doi:10.1371/journal.pone.0115097.t005
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reproducible signal with lower enrichment but higher correlated findings in the
PBMC dataset.
Second, while most relevant changes in gene expression are captured by both
methods, variability seems larger in the WB leading to many transcripts not being
significant when tested with multiple hypotheses.
Third, the globin mRNA depletion method used in the PAXgene stabilized
RNA leads to variable changes in gene expression based on different
concentrations of WB and content of globin transcripts. Globin reduction
protocols [32] [34] [35] [36] [37] have been used to improve microarray data
quality by reducing data variability with increased detection rate of expressed
genes and improved overlap with the expression signatures of isolated PBMC
preparations.
Fourth, the differential composition of cell populations in PBMC and WB
might account for differences in GEP patterns. While PBMC seems to directly
identify changes in a well-defined immunological set of cells, such an assumption
does not apply to WB. In WB, more diverse cell populations including
neutrophils, eosinophils, platelets and reticulocytes among other constituents in
the preparations, reduce the specific cell population of the study. While they have
the potential to be used as biomarkers with the goal of classifying phenotypes, the
Table 6. SVM Misclassification Tables.
A: WB trained SVM applied to PBMC accurately predicts MED and HIGH, with confusion of CTRL and LOW.
CTRL LOW MED HIGH
CTRL 1 6 0 0
LOW 2 5 1 0
MED 0 0 14 0
HIGH 0 0 0 8
B: PBMC trained SVM applied to WB is not good as expected, because the SVM was trained on PBMC genes that were not found to be significant in
WB.
CTRL 2 0 0 1
LOW 0 8 0 0
MED 3 0 10 1
HIGH 4 0 1 3
C: Overlapping PBMC SVM trained applied to PBMC (This means that the subset of genes in PBMC that are the overlapping genes with WB are sufficient
in reproducing the prediction found by the entire set)
CTRL 7 0 0 0
LOW 0 8 0 0
MED 0 0 14 0
HIGH 0 0 0 8
D: Overlapping PBMC SVM trained applied to WB. (This shows that the prediction of the MED and HIGH risk groups based on training the SVM on the
Overlap PBMC gene set is transferrable to the WB dataset. This is the consistency argument we are looking for.)
CTRL 3 0 0 0
LOW 3 3 0 2
MED 0 0 14 0
HIGH 0 0 1 7
doi:10.1371/journal.pone.0115097.t006
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biological meaning of the results is highly questionable when proposing
mechanistic explanations. A comparative analysis revealed that nearly 2,000 genes
with at least a 2-fold average difference in expression between WB and PBMCs
could reflect the difference in cellular composition [18] [22]. Gene expression
associated with WB displays a more pronounced pattern of up-regulation
(Table 5). Theoretically, in both PBMC and WB sampling, analysis is possible
using microfluidics-based flow cytometry-guided cell sorting followed by
subpopulation-specific GEP [38] [39]. However, the intention of our approach, in
creating a clinically feasible protocol, is to use the integrated mixed PBMC
population in the original PBMC protocol and compare it with the WB-approach.
Fifth, the observed differences could also be explained by different RNA
processing methods that have an effect on gene expression profile in WB and
PBMC samples.
Sixth, the results in RT-qPCR showed non-significant differences between the
10 genes when compared to the microarray results.
Lastly, we have obtained high classification rates using both PBMC and WB.
Although PBMC provided more accurate results, classification rates for the
moderate and high risk groups were well discriminated by WB which provides
significant advantages from a methodological and clinical implementation
perspectives.
Limitations
Our findings should be interpreted in consideration of several study limitations
including: 1) limited sample size, 2) lack of power to assess gender specific
variation, 3) variation in the time points of collection dictated by clinical setting,
4) use of the SOFA score which has not been specifically developed for the MCS
population, and 5) use of cross-sectional single time-point evaluations.
Conclusions
We conducted a study to evaluate the comparative usefulness of WB and PBMC
transcriptome analysis in critically ill patients undergoing a complex and high risk
cardiovascular intervention such as MCS therapy. We found that although there
was a significant difference in sensitivity, molecular fingerprints of WB and PBMC
had a good overlap and concordance in their gene expression with common
pathways and mechanisms represented by these genes.
WB as well as PBMC is useful to delineate the inflammatory response associated
with MOD after MCS. While PBMC classification outperformed WB, technical
refinement and development of larger, prospective studies are warranted to
further develop WB biomarkers in critical care settings.
Advantages of PBMC testing include better biological inquiry at the cost of
methodological challenges with difficult implementation in the real world clinical
setting. While WB potentially carries a reduced value in classification performance
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and reflection of actual biology, it has the advantage of easier implementation,
requires a smaller volume, and is more resistant to operational variation. Even
though the critical care setting is associated with many complex interventions,
these do not appear to interfere with the ability of using WB biomarkers to
identify high risk patients.
Supporting Information
S1 Table. Overlapping up- and down-regulated genes expressed in PBMC and
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